Cargando…

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1

Background: Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by hepatic overproduction of oxalate, ultimately responsible for kidney stones, kidney failure and systemic oxalosis. Lumasiran, is a liver-directed RNA interference therapeutic agent. It has been shown to reduce hepatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiodini, Benedetta, Tram, Nathalie, Adams, Brigitte, Hennaut, Elise, Lolin, Ksenija, Ismaili, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767018/ https://www.ncbi.nlm.nih.gov/pubmed/35071135 http://dx.doi.org/10.3389/fped.2021.791616

Ejemplares similares

Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract Infection
por: Hennaut, Elise, et al.
Publicado: (2018)

Early-onset of ADCK4 glomerulopathy with renal failure: a case report
por: Lolin, Ksenija, et al.
Publicado: (2017)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Infantile Primary Hyperoxaluria Type 1 Treated With Lumasiran in Twin Males
por: Aldabek, Khaled, et al.
Publicado: (2022)

Lumasiran for primary hyperoxaluria type 1: What we have learned?
por: Gang, Xuan, et al.
Publicado: (2023)

Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside
por: D’Ambrosio, Viola, et al.
Publicado: (2022)

Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial
por: Ghani, Sundus A., et al.
Publicado: (2023)

Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?
por: Gillion, Valentine, et al.
Publicado: (2022)

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
por: Hulton, Sally A., et al.
Publicado: (2021)

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial
por: Hayes, Wesley, et al.
Publicado: (2022)

Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
por: Kelen, Dorottya, et al.
Publicado: (2021)

Clinical Outcome of Children With Antenatally Diagnosed Hydronephrosis
por: Chiodini, Benedetta, et al.
Publicado: (2019)

A case of failure to thrive secondary to primary hyperoxaluria type 1
por: Stern, Rachel, et al.
Publicado: (2020)

Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study
por: Schaefer, Jan Thomas, et al.
Publicado: (2023)

Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organs
por: Kottos, Elisa, et al.
Publicado: (2021)

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1
por: Loos, Sebastian, et al.
Publicado: (2023)

Fungal infection and neurodevelopmental outcomes at 18–30 months in preterm infants
por: Zhou, Qi, et al.
Publicado: (2023)

Enteric hyperoxaluria in chronic pancreatitis
por: Demoulin, Nathalie, et al.
Publicado: (2017)

Primary Hyperoxaluria Type 1 in 18 Children: Genotyping and Outcome
por: Al Riyami, Mohamed S., et al.
Publicado: (2015)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Prevalence of Mendosal Suture Patency in Infants Up to the Age of 18 Months
por: Escandón, Joseph M., et al.
Publicado: (2022)

Bilateral ureteric re-implant for an 18 months old boy with a huge bilateral hutch diverticulum presented with recurrent urinary retention
por: Aljasser, Abdulrahman, et al.
Publicado: (2020)

Weight loss in adolescents with down syndrome compared to adolescents with other intellectual disabilities enrolled in an 18-month randomized weight management trial
por: Ptomey, Lauren T., et al.
Publicado: (2022)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1
por: Alfadhel, Majid, et al.
Publicado: (2012)

Chronic Nephropathy from Dietary Hyperoxaluria: Sustained Improvement of Renal Function after Dietary Intervention
por: Sun, Yijuan, et al.
Publicado: (2017)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Establishing and Sustaining an ECPR Program
por: Laussen, Peter C., et al.
Publicado: (2018)

Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster
por: Yang, Huan, et al.
Publicado: (2018)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

Primary Hyperoxaluria Involving the Liver With Crystal Deposits
por: Bansal, Nalini, et al.
Publicado: (2019)

ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)

Is stiripentol truly effective for treating primary hyperoxaluria?
por: Martin-Higueras, Cristina, et al.
Publicado: (2020)

Primary hyperoxaluria type 1: pathophysiology and genetics
por: Fargue, Sonia, et al.
Publicado: (2022)

Primary hyperoxaluria: the pediatric nephrologist's point of view
por: Ben-Shalom, Efrat, et al.
Publicado: (2022)

Primary hyperoxaluria: the adult nephrologist's point of view
por: Moochhala, Shabbir H, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7h5i07vmgpp3771c2q42nh73j